TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME

dc.contributor.authorYuldasheva Shokhistakhon Patiddin qizi
dc.date.accessioned2025-12-28T15:24:53Z
dc.date.issued2025-04-16
dc.description.abstractThe disease significantly worsens the quality of life, reduces the social activity of patients, and requires significant material costs for their examination and treatment. In the event that the diagnosis of IBS is established only on the basis of patient complaints, the absence of anxiety symptoms and a minimum number of laboratory and instrumental studies, as recommended in the Rome III criteria, the probability of an incorrect diagnosis remains quite high (up to 25%). The effectiveness of most recommended drugs and regimens in the treatment of IBS does not exceed 38%, which indicates insufficient study of the pathogenesis of the disease.
dc.formatapplication/pdf
dc.identifier.urihttps://theconferencehub.com/index.php/tch/article/view/176
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/8537
dc.language.isoeng
dc.publisherThe Conference Hub
dc.relationhttps://theconferencehub.com/index.php/tch/article/view/176/179
dc.rightshttps://creativecommons.org/licenses/by/4.0
dc.sourceThe Conference Hub; 2025: ICHARSE-USA-APRIL; 49-54
dc.titleTREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
qizi_2025_treatment_of_patients_with_irritable_bow.pdf
item.page.filesection.size
263.27 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections